RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.

Wilmschen, Sarah; Schneider, Sabrina; Peters, Felix; Bayer, Lea; Issmail, Leila; Bánki, Zoltán; Grunwald, Thomas; von Laer, Dorothee; Kimpel, Janine

Wilmschen, Sarah; Schneider, Sabrina; Peters, Felix; Bayer, Lea; Issmail, Leila; Bánki, Zoltán; Grunwald, Thomas; von Laer, Dorothee; Kimpel, Janine.

Afiliación

Wilmschen S; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Schneider S; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Peters F; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Bayer L; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology IZI, 04103 Leipzig, Germany.
Issmail L; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology IZI, 04103 Leipzig, Germany.
Bánki Z; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Grunwald T; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology IZI, 04103 Leipzig, Germany.
von Laer D; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Kimpel J; Division of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Janine.kimpel@i-med.ac.at.

Vaccines (Basel) ; 7(3)2019 Jul 03.

Article en En | MEDLINE | ID: mdl-31277325

Palabras clave

VSV-GP; neutralizing antibodies; respiratory syncytial virus (RSV); viral vector vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google